✦ LIBER ✦

Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo®) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive

✍ Scribed by Hagemeister, Fredrick; Rodriguez, Maria Alma; Deitcher, Steven R.; Younes, Anas; Fayad, Luis; Goy, Andre; Dang, Nam H.; Forman, Arthur; McLaughlin, Peter; Medeiros, Leonard Jeffrey; Pro, Barbara; Romaguera, Jorge; Samaniego, Felipe; Silverman, Jeffrey A.; Sarris, Andreas; Cabanillas, Fernando

Book ID: 120942752
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 190 KB
Volume: 162
Category: Article
ISSN: 0007-1048
DOI: 10.1111/bjh.12446

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vincristine sulfate liposomes injection

Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma : Report of the Pivotal Phase 2 Study

✍ M. A. Rodriguez; Robert Pytlik; Tomas Kozak; Mukesh Chhanabhai; Randy Gascoyne; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 1 views

Phase II Study of Vincristine Sulfate Li

Phase II Study of Vincristine Sulfate Liposome Injection (Marqibo) and Rituximab for Patients With Relapsed and Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma in Need of Palliative Therapy

✍ Kaplan, Lawrence D.; Deitcher, Steven R.; Silverman, Jeffrey A.; Morgan, Gareth 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 203 KB